Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3924-3931

  Linhart, Birgit ^a   Bigenzahn, Sinda ^a   Hartl, Arnulf ^b   Lupinek, Christian ^a   Thalhamer, Josef ^c   Valenta, Rudolf ^a   Wekerle, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CD40 LIGAND MONOCLONAL ANTIBODY; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; POLLEN ANTIGEN;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BASOPHIL; COMBINATION CHEMOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTOPOIESIS; MONOTHERAPY; MOUSE; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; SENSITIZATION; SPLEEN; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 33947263596     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3924     Document Type: Article

References (50)

1. Holt, P. G., and W. R. Thomas. 2005. Sensitization to airborne environmental allergens: unresolved issues. Nat. Immunol. 6: 957-960.
2. Kulig, M., R. Bergmann, U. Klettke, V. Wahn, U. Tacke, and U. Wahn. 1999. Natural course of sensitization to food and inhalant allergens during the first six years of life. J. Allergy Clin. Immunol. 103: 1173-1179.
3. Valenta, R., and D. Kraft. 2002. From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol. 14: 718-727.
4. Valenta, R., T. Ball, M. Focke, B. Linhart, N. Mothes, V. Niederberger, S. Spitzauer, I. Swoboda, S. Vrtala, K. Westritschnig, and D. Kraft. 2004. Immunotherapy of allergic disease. Adv. Immunol. 82: 105-153.
5. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575.
6. Geha, R. S., H. H. Jabara, and S. R. Brodeur. 2003. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3: 721-732.
7. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
8. van Neerven, R. J., E. F. Knol, A. Ejmaes, and P. A. Wurtzen. 2006. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy. Int. Arch. Allergy Immunol. 141: 119-129.
9. Niederberger, V., J. Ring, J. Rakoski, S. Jager, S. Spitzauer, P. Valent, F. Horak, M. Kundi, and R. Valenta. 2007. Antigens drive IgE responses in human allergy via the nasal mucosa. Int. Arch. Allergy Immunol. 142: 133-144.
10. Illi, S., E. von Mutius, S. Lau, B. Niggemann, C. Gruber, U. Wahn, and Multicentre Allergy Study Group. 2006. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 368: 763-770.
11. Larche, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
12. Hahn, C., M. Teufel, U. Herz, H. Renz, K. J. Erb, G. Wohlleben, E. B. Brocker, A. Duschl, W. Sebald, and S. M. Grunewald. 2003. Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma. J. Allergy Clin. Immunol. 111: 1361-1369,
13. Wekerle, T., J. Kurtz, S. Bigenzahn, Y. Takeuchi, and M. Sykes. 2002. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr. Opin. Immunol. 14: 592-600.
14. Vrtala, S., T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, B. Knox, W. R. Sperr, P. Valent, D. Kraft, and R. Valenta. 1998. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 160: 6137-6144.
15. Bluestone, J. A., E. W. St. Clair, and L. A. Turka. 2006. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity. 24: 233-238.
16. + cells. Am. J. Transplant. 1: 339-349.
17. Monk, N. J., R. E. Hargreaves, J. E. Marsh, C. A. Farrar, S. H. Sacks, M. Millrain, E. Simpson, J. Dyson, and S. Jurcevic. 2003. Fc-dependent depletion of activated T cells occurs through CD40L-specific Ab rather than costimulation blockade. Nat. Med. 9: 1275-1280.
18. Kremer, J. M., R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349: 1907-1915.
19. Vincenti, F., C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, G. Blanche, P. Lang, J. Gringo, P. F. Halloran, K. Solez, D. Hagerty, et al., Belatacept Study Group. 2005. Costimulation blockade with belatacept in renal transplantation. N. Engl J. Med. 353: 770-781.
20. Vrtala, S., M. Susani, W. R. Sperr, P. Valent, S. Laffer, C. Dolecek, D. Kraft, and R. Valenta. 1996. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). J. Allergy Clin. Immunol. 97: 781-787.
21. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
22. Blaha, P., S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H, Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al. 2003. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101: 2886-2893.
23. Schaub, M., S. Issazadeh, T. H. Stadibauer, R. Peach, M. H. Sayegh, and S. J. Khoury. 1999. Costimulatory signal blockade in tnurine relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 96: 158-166.
24. Bigenzahn, S., P. Blaha, Z. Koporc, I. Pree, E. Selzer, H. Bergmeister, F. Wrba, C. Heusser, K. Wagner, F. Muehlbacher, and T. Wekerle. 2005. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am. J. Transplant. 5: 1237-1247.
25. Flicker, S., S. Vrtala, P. Steinberger, L. Vangelista, A. Bufe, A. Petersen, M. Ghannadan, W. R. Sperr, P. Valent, L. Norderhaug, et al. 2000. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain. J. Immunol. 165: 3849-3859.
26. Vrtala, S., P. Mayer, F. Ferreira, M. Susani, A. H. Sehon, D. Kraft, and R. Valenta. 1996. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2. J. Allergy Clin. Immunol. 98: 913-921.
27. Westritschnig, K., M. Focke, P. Verdino, W. Goessler, W. Keller, A. Twardosz, A. Mari, F. Horak, U. Wiedermann, A. Hartl, et al. 2004. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7. J. Immunol. 172: 5684-5692.
28. Valenta, R. 2002. The future of allergen-specific immunotherapy. Nat. Rev. Immunol. 2: 446-453.
29. Abrams, J. R., M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, M. T. Goldfarb, B. S. Goffe, A. Menter, N. J. Lowe, G. Krueger, M. J. Brown, et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103: 1243-1252.
30. Van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
31. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1: 423-431.
32. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617-620.
33. Tang, A., T. A. Judge, B. J. Nickoloff, and L. A. Turka. 1996. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157: 117-125.
34. Khoury, S. J., E. Akalin, A. Chandraker, L. A. Turka, P. S. Linsley, M. H. Sayegh, and W. W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155: 4521-4524.
35. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181: 1869-1874.
36. Vieira, P., and K. Rajewsky. 1990. Persistence of memory B cells in mice deprived of T cell help. Int. Immunol. 2: 487-494.
37. Hebeis, B. J., K. Klenovsek, P. Rohwer, U. Ritter, A. Schneider, M. Mach, and T. H. Winkler. 2004. Activation of virus-specific memory B cells in the absence of T cell help. J. Exp. Med. 199: 593-602.
38. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
39. Ochsenbein, A. F., D. D. Pinschewer, S. Sierra, E. Horvath, H. Hengartner, and R. M. Zinkernagel. 2000. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 97: 13263-13268.
40. Bell, E. B., S. Hayes, M. McDonagh, C. Bunce, C. Yang, and S. M. Sparshott. 2001. Both CD45R(low) and CD45R(high) 'revenant' CD4 memory T cells provide help for memory B cells. Eur. J. Immunol. 31: 1685-1695.
41. Larche, M., and D. C. Wraith. 2005. Peptide-based therapeutic vaccines for allergic and autoimmune disease. Nat. Med. 11: S69-76.
42. Simons, F. E., M. Imada, Y. Li, W. T. Watson, and K. T. HayGlass. 1996. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int. Immunol. 8: 1937-1945.
43. Larche, M., S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson. 1998. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J. Immunol. 161: 6375-6382.
44. Krinzman, S. J., G. T. De Sanctis, M. Cernadas, D. Mark, Y. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, et al. 1996. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98: 2693-2699.
45. Harris, N., R. Peach, J. Naemura, P. S. Linsley, G. Le Gros, and F. Ronchese. 1997. CD80 costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 185: 177-182.
46. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle. 1997. Costimulation through B7-2 (CD86) is required for the induction of lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185: 1671-1679.
47. Keane-Myers, A., W. C. Cause, P. S. Linsley, S. Chen, and M. Wills-Karp. 1997. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158: 2042-2049.
48. Kroczek, R., and E. Hamelmann. 2005. T-cell costimularory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J. Allergy Clin. Immunol. 116: 906-909.
49. Kurtz, J., T. Wekerle, and M. Sykes. 2004. Tolerance in mixed chimerism - a role for regulatory cells? Trends Immunol. 25: 518-523.
50. Coffman, R. L. 2006. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat. Immunol. 7: 539-541.